MARKET

CPHI

CPHI

China Pharma
AMEX
0.1462
+0.0062
+4.43%
Opening 15:54 10/04 EDT
OPEN
0.1534
PREV CLOSE
0.1400
HIGH
0.1576
LOW
0.1401
VOLUME
213.14K
TURNOVER
18.05K
52 WEEK HIGH
0.7899
52 WEEK LOW
0.1300
MARKET CAP
7.38M
P/E (TTM)
-1.8577
1D
5D
1M
3M
1Y
5Y
China Pharma gets NYSE American listing deficiency notice
China Pharma (NYSE:CPHI) <a href="https://seekingalpha.com/p...
Seekingalpha · 1d ago
China Pharma Holdings Receives Non-Compliance Notice from NYSE American
China Pharma Holdings Receives Non-Compliance Notice from NYSE American
MT Newswires · 1d ago
China Pharma Announced Receipt of Notification of NYSE American Listing Deficiency
China Pharma Holdings, Inc. (NYSE American: CPHI; the &#34;Company&#34;) today announced that on September 26, 2022, the Company received notification (the &#34;Deficiency Letter&#34;) from the NYSE AMERICAN LLC (&#34;NYSE American&#34;) informing it that the Company is not in compliance with certain NYSE American continued listing standards (the &#34;Listing Standards&#34;).
Benzinga · 2d ago
BRIEF-China Pharma Announces Receipt Of Notification Of NYSE American Listing Deficiency
BRIEF-China Pharma Announces Receipt Of Notification Of NYSE American Listing Deficiency
Reuters · 2d ago
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Gainers
Benzinga · 09/23 07:42
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
 Gainers
Benzinga · 09/22 16:26
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
Benzinga · 09/22 10:34
China Pharma Announced the Submission of a Plan of Compliance to NYSE American
China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on July 15, 2022, the Company submitted a plan of compliance to NYSE American LLC ("NYSE American" or the "E...
PR Newswire · 07/18 12:00
More
About CPHI
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

Webull offers kinds of China Pharma Holdings, Inc. stock information, including AMEX:CPHI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPHI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CPHI stock methods without spending real money on the virtual paper trading platform.